Timolol / Dorzolamide Formulation

Hazard statements (CLP)

H372

Code

Statements

H372

Causes damage to organs through prolonged or repeated exposure

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H372 Causes damage to organs (Cardio-vascular sys- tem, Central nervous system, Gastrointestinal tract, Lungs) through prolonged or repeated expo- sure.

Prevention

P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this prod- uct.

Response

P314 Get medical advice/ attention if you feel unwell.

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) Specific target organ toxicity - repeated H372: Causes damage to organs through pro- exposure, Category 1, Cardio-vascular longed or repeated exposure. system, Central nervous system, Gastro- intestinal tract, Lungs